Uzbekistan plans to fundamentally reform the pricing policy in the pharmaceutical market, reported Gazeta.uz. According to the new project presented to the president, starting from January 1, 2026, the average price of 2,600 types of prescription medicines will be reduced by 40–50 percent.
Currently, there are 7,600 imported medicines available in the country’s market, of which about 4,900 are not included in international price registries. This allows importers to independently set prices, which in some cases leads to medicines being sold significantly more expensively than in neighboring countries.
The new system will be implemented through a “reference price registry,” which will be based on officially approved prices in countries such as Russia, Kazakhstan, and the European Union. Through this mechanism, medicine prices will be transparently regulated, and unjustified price increases will be prevented.
From now on, the practice of free pricing for pharmacies and importers will be abolished. As a result, citizens will gain wider access to affordable and high-quality medicines.
Experts note that the effectiveness of the system will depend on the work of regulatory bodies and the stability of supply. The new regulation is expected to eliminate artificial price hikes, excessive profits, and market instability.
Read “Zamin” on Telegram!
